<DOC>
	<DOC>NCT00851578</DOC>
	<brief_summary>The purpose of the study is to characterize the performance of the WATCHMAN LAA Closure Device in atrial fibrillation patients for which long term warfarin therapy is contraindicated.</brief_summary>
	<brief_title>ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure Technology</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>18 years of age or older paroxysma, persistent, or permanent nonvlavular atrial fibrillation contraindicated to warfarin eligible for clopidogrel, ticlopdine, heparin, or aspirin CHADS score 1 or greater NYHA Class IV LAA obliteration Heart transplant LVEF less than 30% greater than 50% carotid stenosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>AF</keyword>
	<keyword>atrial fibrillation</keyword>
	<keyword>LAA occlusion</keyword>
</DOC>